Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Coral Laboratories Limited

Market Cap 1.32B 14.03M 12.23M 11.33M 10.61M 19.89M 20.01M 134M 52.09M 652M 52.66M 51.53M 2.26B P/E 2024
8.4x
P/E 2025 10.4x
Enterprise Value 1.05B 11.13M 9.7M 8.99M 8.41M 15.78M 15.87M 107M 41.31M 517M 41.77M 40.87M 1.79B EV / Sales 2024
1.25x
EV / Sales 2025 1.94x
Free-Float
19.98%
Yield 2024
0.54%
Yield 2025 0.21%
1 day+9.89%
1 week+12.18%
Current month+16.15%
1 month+20.30%
3 months+32.02%
6 months+20.45%
Current year+25.30%
1 week 495
Extreme 495
557.9
1 month 444
Extreme 444
557.9
Current year 360
Extreme 360
557.9
1 year 360
Extreme 360
624.95
3 years 230
Extreme 230
999
5 years 217
Extreme 217
999
10 years 81.2
Extreme 81.2
1,190
Manager TitleAgeSince
Director of Finance/CFO 49 25/05/2017
Director TitleAgeSince
Director/Board Member 45 25/05/2017
Director/Board Member 49 25/05/2017
Director/Board Member 40 27/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+9.89%+12.18%-6.64%+132.47% 20.8M
-1.21%-3.04%+44.03%+143.07% 980B
-2.48%-5.18%+52.47%+39.15% 550B
-2.14%-4.94%+16.83%+57.08% 382B
+0.25%-3.09%+23.33%+16.04% 316B
+0.61%-1.69%+27.35%+13.73% 272B
+0.22%-3.10%+24.67%+30.49% 268B
+4.59%+1.98%-38.43%-46.26% 199B
-1.19%-4.95%+16.68%+47.69% 182B
-1.35%-1.46%+14.06%+59.26% 154B
Average +0.72%-1.50%+17.44%+49.27% 330.24B
Weighted average by Cap. -0.78%-3.68%+29.49%+63.31%

Financials

2024 2025
Net sales 837M 8.87M 7.73M 7.16M 6.7M 12.57M 12.65M 84.94M 32.92M 412M 33.28M 32.57M 1.43B 1.15B 12.19M 10.63M 9.84M 9.21M 17.28M 17.38M 117M 45.25M 566M 45.75M 44.77M 1.97B
Net income 158M 1.67M 1.46M 1.35M 1.26M 2.37M 2.39M 16.03M 6.21M 77.72M 6.28M 6.15M 270M 242M 2.56M 2.23M 2.07M 1.94M 3.63M 3.65M 24.52M 9.5M 119M 9.61M 9.4M 413M
Net Debt -278M -2.94M -2.57M -2.38M -2.23M -4.17M -4.2M -28.21M -10.93M -137M -11.05M -10.82M -475M -274M -2.9M -2.53M -2.34M -2.19M -4.12M -4.14M -27.81M -10.78M -135M -10.9M -10.66M -468M
Logo Coral Laboratories Limited
Coral Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in the business of pharmaceutical formulations. The Company is engaged in the manufacturing of generic - branded, nutraceuticals, over the counter (OTC), and herbal medicines. It offers dosage forms, which include tablets, capsules, liquid orals, injections (liquids and powder), ointment and creams, gels and lotions, and suppositories. Its product categories include nutraceutical, OTC, sterile and non-sterile. Its nutraceutical products include DAX 200, DAX 400 Drops, Zest drops, and Super Zestcal Tablets. Its OTC products include herbal range, skin care, medical devices, and effervescent range. Its sterile products include small volume liquid - injectables, lyophilized range - injectables, eye drops, and eardrops. Its non-sterile antibiotics/antibacterials, antifungals, gastro-intestinal drugs, anti-emetics, and muscle relaxants. The Company also exports its products to various countries.
Employees
197
Date Price Change Volume
19/06/26 549.45 +9.89% 6,717
18/06/26 500.00 -0.74% 341
17/06/26 503.75 +0.26% 1,243
16/06/26 502.45 +0.36% 495
15/06/26 500.65 +2.22% 2,368
  1. Stock Market
  2. Stocks
  3. CORALAB6 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!